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The instability of chromosome fragile sites is implicated as a
causative factor in several human diseases, including cancer [for
common fragile sites (CFSs)] and neurological disorders [for rare
fragile sites (RFSs)]. Previous studies have indicated that problems
arising during DNA replication are the underlying source of this
instability. Although the role of replication stress in promoting
instability at CFSs is well documented, much less is known about
how the fragility of RFSs arises. Many RFSs, as exemplified by
expansion of a CGG trinucleotide repeat sequence in the fragile X
syndrome-associated FRAXA locus, exhibit fragility in response to
folate deficiency or other forms of “folate stress.” We hypothe-
sized that such folate stress, through disturbing the replication
program within the pathologically expanded repeats within
FRAXA, would lead to mitotic abnormalities that exacerbate locus
instability. Here, we show that folate stress leads to a dramatic
increase in missegregation of FRAXA coupled with the formation
of single-stranded DNA bridges in anaphase and micronuclei that
contain the FRAXA locus. Moreover, chromosome X aneuploidy is
seen when these cells are exposed to folate deficiency for an ex-
tended period. We propose that problematic FRAXA replication
during interphase leads to a failure to disjoin the sister chromatids
during anaphase. This generates further instability not only at
FRAXA itself but also of chromosome X. These data have wider
implications for the effects of folate deficiency on chromosome
instability in human cells.
CGG trinucleotide repeats | chromosome missegregation |
folate deficiency | FRAXA | RPA UFB
Achromosome fragile site is a locus that is prone to form agap or break in an otherwise condensed metaphase chro-
mosome. Based on their prevalence, these loci are defined as
being either common fragile sites (CFSs), which are present in all
individuals, or rare fragile sites (RFSs), which exist in less than
5% of the population. CFS and RFS instability can be induced by
exposure of cells to agents that interfere with DNA metabolism;
however, the inducing agent in each case differs. CFSs are
classified as being aphidicolin (APH)-inducible, bromodeoxyur-
idine (BrdU)-inducible, or 5-azacytidine−inducible, while RFSs
are classified as being folate-inducible or non−folate-inducible
(1). While CFS instability is recognized as a driver of genome
instability in cancers (2), many RFSs are associated with in-
tellectual disability disorders (3). To date, much of our un-
derstanding of the underlying cause of fragile site instability has
been derived from studies of CFSs.
CFS fragility is induced by conditions that create so-called
DNA replication stress. It is generally considered that CFS
“expression,” defined as the presence of a visible gap/break on a
metaphase chromosome, results from a localized inability to
properly condense the DNA during early mitosis due to in-
complete DNA replication of the locus during interphase (3, 4).
The cause of the replication failure is still debated, but increasing
evidence suggests that conflicts arising during attempted repli-
cation and transcription of the same DNA template are a key
driver. We have demonstrated previously that, under replication
stress conditions, CFSs are marked by the presence of the
FANCD2 and FANCI proteins irrespective of whether the locus
is broken or not. These proteins appear at CFS loci as “twin foci”
on the sister chromatids in metaphase spreads (5). Many of these
FANCD2 foci persist into anaphase and become interlinked by
PICH-associated ultrafine DNA bridges (UFBs) (5, 6). More-
over, CFSs have a propensity to be segregated into a micronu-
cleus at the end of mitosis (5, 7), which is a potential source of
further genome instability in the daughter cells.
Folate is an essential vitamin that provides the one-carbon
source necessary for DNA synthesis. Because folate cannot be
synthesized in the human body, dietary sources are essential, and
deficiency is, therefore, widespread in human populations af-
fected by malnutrition or where supplementation with folic acid
is lacking. To date, folate deficiency is known to be associated
with anemia, fetal neural tube defects, infertility in men and
women, a wide range of common cancers, psychological disor-
ders, and age-associated dementia (8–17). Previous analyses
have suggested that folate deficiency could lead to the formation
of micronuclei, nucleoplasmic bridges, and nuclear buds in hu-
man lymphocytes (18). Moreover, folate deficiency drives chro-
mosome instability (e.g., chromosome 21 aneuploidy) (19) and
DNA replication-associated DNA breakage (20). Nonetheless, it
remains largely mysterious how folate deficiency can cause
widespread genome instability in human cells. Interestingly, it is
well established that a subgroup of RFSs that are characterized
by the presence of CGG trinucleotide repeat (TNR) sequences is
particularly susceptible to folate deficiency (1). When these TNR
sequences expand beyond a critical size, the development of
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specific neurological diseases can be triggered; most notably,
fragile X syndrome (FXS), the most common inherited form of
mental retardation (21–24).
The CGG TNR sequence that becomes pathologically ex-
panded in FXS is located at the FRAXA locus on the long arm of
chromosome X (ChrX) (at Xq27.3). This TNR lies within the 5′
untranslated region of the fragile X mental retardation 1 gene
(FMR1) (24). In the healthy population, this repeat ranges in
length from 6 to 53 triplets, and this locus is stably transmitted to
the next generation (23). When the repeat reaches the pre-
mutation range (PM; 55 to 200 repeats), it is then prone to expand
to a full mutation (FM; >200 repeats) in the next generation (23).
FM cases are accompanied by increased methylation of the pro-
moter region of FMR1. This leads to FMR1 gene silencing and
reduced expression of FMRP protein (25), which is the direct
cause of the symptoms associated with FXS (26). Furthermore,
ChrX aneuploidy has been observed in female carriers (27) and in
male FXS patients (28–30), but the mechanism underlying this
form of FRAXA instability also remains unknown. It has been
speculated that an atypical DNA structure formed by the CGG
repeat itself, such as a hairpin-like structure (31), quadruplex (32),
or R loop (33, 34), could contribute to its instability. Interestingly,
repeat-length mosaicism has also been reported in PM and FM
fragile X males. In these cases, skin and blood cells tend to have
different repeat lengths at FRAXA, which is associated with vari-
able expression of FMRP. This suggests the fragile X CGG repeat
is unstable in somatic tissue during embryogenesis and perhaps
during early development. It is also intriguing that folate-sensitive
RFSs have two features that distinguish them from CFSs: (i) They
are found only associated with long CGG repeats; and (ii) they are
located at the promoters of genes whose transcription is generally
silenced due to the expansion of CGG repeats, indicating that the
fragility of RFSs is unlikely to be caused by the collision between
the replication fork and an unprocessed transcript, as has been
proposed for CFSs.
Against this backdrop, we hypothesized that folate deficiency
would specifically affect the replication program in genomic re-
gions containing CGG repeats, and that this would then lead to
mitotic abnormalities similar to those observed at CFSs. In this
study, we used a panel of lymphocytes derived from males who
have a normal, PM, or FM FRAXA allele to examine mitosis
under folate stress conditions. We demonstrate that folate de-
ficiency leads to a dramatic defect in the segregation of FM
FRAXA in mitosis. We also reveal that ChrX aneuploidy is ob-
served during extended folate stress in the FM cell line. We
propose, therefore, that folate deprivation can trigger chromo-
some instability due to defective mitotic sister chromatid dis-
junction of genomic regions containing long CGG repeats.
Results
FRAXA Exhibits Fragility and Is Missegregated in Mitosis During
Folate Stress. We analyzed a panel of immortalized male hu-
man lymphocytes that have normal, PM, or FM FRAXA alleles
(SI Appendix, Fig. S1 A and B); these cell lines will henceforth be
referred to as normal, PM, or FM cells, respectively. To track the
location of FRAXA in mitosis, we performed fluorescence in situ
hybridization (FISH) using DNA probes targeting either the
FRAXA locus or the ChrX centromere (ChXCEN). It was shown
previously that disruption of thymidine synthesis induced either
by folate deprivation or by treatment with the thymidylate syn-
thetase inhibitor, fluorodeoxyuridine (FdU), could cause the
fragility at FRAXA in lymphocytes from FM carriers (35). We
first confirmed that FRAXA fragility could indeed be induced in
the FM cell line GM09237, either by exposure of cells to 0.5 μM
FdU or by culturing them in the absence of folate for 3 d (SI
Appendix, Fig. S1 C–F). As expected, we also observed that
neither APH nor hydroxyurea could cause fragility at FRAXA in
the FM cell line, GM09237 (SI Appendix, Fig. S1E).
We then investigated whether the FRAXA locus could gener-
ate chromatin bridges or UFBs in anaphase in response to either
FdU or the absence of folate, as has been observed at CFSs in
cells treated with APH (5). To this end, lymphocytes were treated
with either FdU for 17 h or deprived of folate for 3 d (“No folate”),
and then arrested in late G2 phase with the CDK1 inhibitor
RO3306 (36), before being released into mitosis (Fig. 1A). Inter-
estingly, we observed that the FRAXA locus was located on chro-
matin bridges and on lagging chromatin in all of the cell lines
tested, although with markedly different frequencies (Fig. 1 B–D).
Fd
U
Un
t
DAPI ChXCEN FRAXADAPI
GM09237
B
***
RO3306
A
C
GM
20
23
0
(47
 re
pe
ats
)
GM
06
89
1
(10
0-1
17
 re
pe
ats
)
GM
06
85
2
(>2
00
 re
pe
ats
)
GM
09
23
7
(>9
00
 re
pe
ats
)
GM
06
86
5 
(27
 re
pe
ats
)
%
 F
RA
XA
 +
ve
 D
N
A 
br
id
ge
s 
/  
la
gg
in
g 
ch
ro
m
at
in
  (n
=8
0-1
22
)
0
10
20
30
40
50
60
70
Unt FdU ****
%
 F
R
AX
A 
+v
e 
DN
Ab
rid
ge
s/
 
la
gg
in
g 
ch
ro
m
at
in
(n=
91
-13
7)
GM
06
89
1
(10
0-1
17
 re
pe
ats
)
GM
06
85
2
(>2
00
 re
pe
ats
)
GM
09
23
7
(>9
00
 re
pe
ats
)
GM
06
86
5 
(27
 re
pe
ats
)
0
10
20
30
40 Unt No folate
-/+ FdU 
17 hours 9 hours
 RO3306 
Harvest 
ana/telo-phase 
cells
Asynchronous 
cells
ReleaseG2 phase 
arrest 30/45 min
perturbed
S phase
No folate 
72 hours
9 hours
D
Fig. 1. FRAXA is located on DNA bridges and lagging
chromatin in response to folate stress. (A) Experi-
mental workflow for the analysis of lagging chromatin
and anaphase bridges in cells following FdU treatment
for 17 h (FdU) or folate deprivation for 3 d (No folate).
(B) Representative images and (C) quantification of
lagging chromatin and anaphase bridges containing
the FRAXA locus in a panel of lymphocyte cell lines
following FdU treatment. Unt, untreated. White ar-
rows in B denote the location of FRAXA. (Scale bar in
B: 5 μm.) (D) Quantification of lagging chromatin
and anaphase bridges containing the FRAXA locus in a
panel of lymphocyte cell lines following folate depri-
vation. Data are means of at least three independent
experiments. Error bars represent SDs. ***P < 0.001;
****P < 0.0001.
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In particular, aberrant mitotic segregation of FRAXA was seen
strikingly in the FM GM09237 cell line containing more than 900
CGG repeats, reaching a level of 50% of the anaphases following
FdU treatment and 30% of the anaphases following folate depri-
vation (Fig. 1 B–D). In addition, we confirmed that exposure to
APH did not lead to missegregation of FRAXA in either the FM
cells or a cell line containing normal FRAXA (GM20230), and that
FdU did not induce CFS-associated anaphase bridges [using the
widely studied CFS locus, FRA16D, as an example (37)] (SI Ap-
pendix, Fig. S2).
FRAXA Localizes to Anaphase DNA Bridges Containing Single-Stranded
DNA. Because many of the FRAXA-containing chromatin bridges
were apparently discontinuous and contained regions that were
not stained by DAPI (Fig. 1B), we hypothesized that such DAPI-
negative “gaps” might harbor UFBs. To test this hypothesis, we
analyzed whether the PICH protein (6, 38), an established marker
of UFBs, was present in these gaps (Fig. 2A). Surprisingly, PICH
was rarely found in DAPI-negative regions of the DNA bridges
containing FRAXA (Fig. 2B). Because PICH binds only to double-
stranded DNA (dsDNA) (39), we examined whether RPA, the
major single-stranded DNA (ssDNA) binding protein in human
cells, might be present in the DAPI-negative gaps instead. Our
results indicate that this was the case: Most of the gaps contained
a UFB that was coated by RPA along almost all of its length
(designated “RPA+ve” UFBs) (Fig. 2B). In addition, we observed
that the staining patterns for PICH and RPA were generally
mutually exclusive in those rare cases where UFBs were decorated
by both of these proteins (designated “PICH/RPA+ve” UFBs)
(Fig. 2C). Quantification of the frequency of PICH+ve, RPA+ve,
or PICH/RPA+ve UFBs revealed that FdU treatment had a
minimal effect on the spectrum of different UFB types in the cell
line with normal FRAXA allele. In contrast, the cell line with FM
FRAXA allele exhibited a significant increase of RPA+ve UFBs in
response to FdU treatment (Fig. 2D). Furthermore, we confirmed
that RPA+ve UFBs were also frequently observed in the No folate
condition (Fig. 2 A and E). As a control, and consistent with pre-
vious findings, the majority of the UFBs induced by APH treatment
were PICH+ve, and not RPA+ve (Fig. 2 A and E).
The discovery of FRAXA-associated, RPA+ve UFBs is in-
triguing because the presence of RPA-coated UFBs has only
been observed in a small number of previous studies. These
RPA-coated UFBs have been proposed to represent either
underreplicated DNA or unresolved homologous recombination
(HR) intermediates (40, 41). We therefore assessed whether the
RPA-associated UFBs arising at FRAXA in response to FdU are
dependent upon the major recombinase in human cells, RAD51.
We observed that, following addition of the RAD51 inhibitor,
RI-1, in G2 cells, there was a striking decrease in the frequency
of RPA+ve UFBs and a concomitant increase in PICH+ve UFBs
(Fig. 2 A and F and SI Appendix, Fig. S4). These data suggest that
RPA+ve UFBs arise due to persistence of unprocessed HR in-
termediates, rather than underreplication per se.
The above finding also prompted us to ask whether the pro-
teins involved in marking the location of CFSs following APH
treatment are also found at FRAXA under folate stress condi-
tions. We therefore analyzed whether FANCD2 colocalizes with
either the FRAXA locus or the RPA+ve UFBs in response to
FdU treatment (SI Appendix, Fig. S3). In this analysis, we fo-
cused on the FdU treatment only, since this treatment induces a
higher rate of RPA+ve UFBs than does folate deprivation. We
only rarely detected colocalization of FANCD2 with FRAXA
following FdU treatment of cells with either a normal FRAXA
allele (GM06865) or an FM allele (GM09237) (SI Appendix, Fig.
S3 A–C). Moreover, although FANCD2 was occasionally de-
tected at the ends of PICH-associated UFBs, the vast majority of
the RPA+ve UFBs induced by FdU treatment were FANCD2-
negative (SI Appendix, Fig. S3 D–F).
FRAXA Is Located in Micronuclei and Is Missegregated During Folate
Stress. To investigate whether the aberrantly segregated DNA
containing FRAXA could disrupt the normal inheritance of the
FRAXA locus in daughter cells, we analyzed cytokinesis-blocked
“twin-daughter” G1 cells using FISH to define the location of
FRAXA. To ensure that we analyzed only the cells that had
undergone a perturbed round of DNA replication in the pres-
ence of FdU, we labeled cells that had traversed S phase by in-
cubating them with 5-ethynyl-2′-deoxyuridine (EdU) for 3 h
following FdU treatment (Fig. 3A and SI Appendix, Fig. S5).
Hence, we only scored binucleated (twin-daughter) G1 cells that
were EdU-positive. Consistent with the significantly high fre-
quency of FRAXA-containing DNA bridges in anaphase in FM
cells, we observed an increased frequency of FRAXA loss in one of
the daughter nuclei in these cells, an effect that was not seen in the
cells with a normal FRAXA allele (Fig. 3 B and C). In addition,
25% of the FM daughter cells contained a FRAXA-positive
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Fig. 2. FM FRAXA is associated with RPA-coated
UFBs in response to folate stress. (A) Experimental
workflow for DNA bridge analysis in anaphase fol-
lowing treatment with FdU, APH, or deprivation of
folate for 3 d. For cells treated with FdU, some were
also treated with the RAD51 inhibitor, RI-1, during
the final stages of G2. (B) Representative images of
FRAXA+ve UFBs coated by RPA. FRAXA was detected
using a specific FISH probe, and RPA was detected
using an RPA antibody by IF. (C) Representative im-
ages and (D) quantification of PICH+ve, RPA+ve, or
PICH/RPA+ve UFBs in GM06865 or GM09237 cells. (E)
Quantification of PICH+ve, RPA+ve, or PICH/RPA+ve
UFBs in GM09237 cells following the indicated treat-
ments. (F ) Quantification of PICH+ve, RPA+ve, or
PICH/RPA+ve UFBs in GM09237 cells following FdU
treatment in S phase and RI-1 treatment in late G2. In
B and C, white arrows denote the FRAXA+ve lagging
DNA. (Scale bar in B and C: 5 μm.) Data are means of
at least three independent experiments. Error bars
represent SDs. *P < 0.05; **P < 0.01; ***P < 0.001;
****P < 0.0001.
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micronucleus, a greater than fivefold increase in comparison
with that of normal cells (Fig. 3 D and E). To verify whether
ChXCEN was missegregated together with FRAXA in FM cells
following FdU treatment, we conducted the same experiment
using a FISH probe specific for ChXCEN. However, none of
the micronuclei scored contained ChXCEN, and none of the
daughter nuclei analyzed had lost ChXCEN (Fig. 3D, Bottom).
Taken together, our data indicate that, during only a single
cell cycle, FdU treatment of FM cells causes extensive mitotic
missegregation of FRAXA, but not of ChrX in its entirety.
To investigate whether folate deprivation might also cause the
mislocalization and/or loss of FRAXA in the daughter cells, we
cultured cells without folate for 3 d and then analyzed cytokinesis-
blocked twin-daughter G1 cells as above (Fig. 3A). We observed a
clear increase in the frequency of FRAXA loss in the cells con-
taining either a normal or a mutant FRAXA allele (Fig. 3 F and
G). More strikingly, we observed a strong increase in the com-
bined loss of FRAXA and ChXCEN, or the loss of only the cen-
tromere, in cells with a mutant FRAXA allele (Fig. 3 F and G).
Unlike FdU treatment, however, folate deprivation led to only
a modest increase in the frequency of micronuclei containing
FRAXA (Fig. 3 E and H). One likely explanation for this is that
any FRAXA-containing micronuclei would be lost from the pop-
ulation during the extended growth period required to deprive
cells of folate.
FRAXA and ChrX Are Unstable During Extended Folate Deprivation. In
addition to missegregation of FRAXA in cells deprived of folate,
we also observed an accumulation of binucleated progeny (4N
cells) (SI Appendix, Fig. S6A). This was particularly evident when
cells were cultured without folate for 5 d (SI Appendix, Fig. S6B).
We reasoned that these binucleated cells would likely result from
cytokinesis failure due to the presence of unresolved DNA
bridges in telophase. This prompted us to address whether the
abnormal segregation of FRAXA discussed above might be as-
sociated with the appearance of 4N cells. We therefore analyzed
the segregation of ChrX in the cells deprived of folate for 5 d
using FISH probes targeting either FRAXA or ChXCEN. We
observed that there was a significantly greater increase in the
frequency of abnormal segregation of FRAXA in the 4N progeny
than in the 2N progeny in both normal and FM cells (Fig. 4 A–
C). Interestingly, there was also a small, but measurable, increase
of ChXCEN being missegregated in the 4N FM cells (Fig. 4 A–
C). To investigate this in more detail, the location of FRAXA and
ChXCEN was analyzed on metaphase chromosome spreads de-
rived from either diploid (2N) or tetraploid) 4N cells deprived of
folate (Fig. 4D). This showed that the FRAXA locus was either
lost or located at an ectopic site in around 5% of the FM 4N cells
but not in 2N cells or the 4N normal cells (Fig. 4E, Left, and F).
Moreover, in some rare cases, the entire ChrX was lost in FM 4N
cells (see example in Fig. 4E, Right). It is intriguing that the
mitotic missegregation of FRAXA in the 4N cells was far more
frequent than was the complete loss of FRAXA. We reasoned
that this simply reflects the fact that a catastrophic chromosome
event (e.g., the lagging DNA containing FRAXA or ChxCEN)
can be captured while it is occurring in anaphase (Fig. 4B), but
the majority of such events would lead to a change in ploidy or
chromosome structure and hence cell death in the following cell
cycles, which could not be scored in the metaphase spread
analysis (Fig. 4 E and F).
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Fig. 3. FM FRAXA is frequently located in a micronucleus, or lost in daughter G1 cells following folate stress. (A) Experimental workflow for quantifying FRAXA
loss in cytokinesis-blocked G1 twin cells following FdU treatment for 17 h or folate deprivation for 3 d. (B) Representative images and (C) quantification of G1 cells that have
lost FRAXA. White arrows denote FRAXA located in the nucleus. (D, Top) Representative images of the location of FRAXA in G1 cells in untreated cells. (Middle) Repre-
sentative images of FRAXA locatedwithin amicronucleus in FdU treated cells allowed to progress into G1. (Bottom) Representative images of the location of ChXCEN in FdU
treated cells. White arrows denote FRAXA in the nucleus, and yellow arrow denotes FRAXA located in a micronucleus. The location of FRAXA or ChXCENwas detected by
the relevant FISH probe. (E) Quantification ofmicronuclei containing FRAXA in G1 cells following FdU treatment of GM06865 or GM09237 cells. (F) Representative images of
GM09237 G1 cells that have lost either FRAXA (Lower, second from right), or ChxCEN (Lower, right), or both FRAXA and ChxCEN (Lower, second from left) following 3 d of
folate deprivation. Upper, phase contrast images of nuclei stained with DAPI. (G) Quantification of the events observed in F in GM06865 or GM09237 cells. White arrows
denote FRAXA, and yellow arrows denotes ChxCEN. FRAXA and ChxCEN were detected by a FISH probe. (H) Quantification of micronuclei containing FRAXA in G1
cells following 3 d folate deprivation in GM06865 or GM09237 cells. (Scale bar in B, D, and F: 5 μm.) Data are means of at least three independent experiments. Error bars
represent SDs. **P < 0.01; ***P < 0.001; ****P < 0.0001.
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PM Allele Becomes Unstable Under Folate Stress. Following the
observation of dramatic changes at FRAXA in response to folate
stress, we investigated whether folate stress might affect the
stability of CGG repeats. To this end, we cultured cells in the
absence or presence of folate stress (with FdU for 17 h, or no
folate for 5 d), and then seeded cells as small populations (200
cells per well; designated “pooled clones”) in normal medium for
2 wk. Subsequently, we extracted DNA from each population of
pooled clones and analyzed the distribution of FMR1 CGG allele
sizes (SI Appendix, Fig. S7A). We observed that the normal
FMR1 CGG allele remains stable under these conditions, with
the PCR products from all of the pooled clones varying in size by
no more than the equivalent of two CGG repeats (SI Appendix,
Fig. S7B and Table S1). In contrast, there was significantly more
variation in CGG allele length in the PM pooled clones, par-
ticularly in those cells that had been cultured under folate stress
conditions, resulting in a decrease in the proportion of the
population containing the initial allele length (SI Appendix, Fig.
S7 C and D and Table S1 and Dataset S1). Moreover, there was a
tendency for the PM allele to contract in size during folate stress
(SI Appendix, Fig. S7 C, E, and F and Table S1 and Dataset S1).
Discussion
To further understand the mechanism underlying the instability
of folate-sensitive RFSs, we have analyzed the mitotic segrega-
tion of FRAXA, a locus containing an unstable CGG TNR. Our
data demonstrate that folate stress causes a high level of mitotic
instability in cells harboring a pathologically expanded CGG TNR
region. Specifically, the FM FRAXA locus displays increased fra-
gility in metaphase and aberrant segregation to daughter cells
when the cells are treated with FdU or deprived of folate for a 3-d
period, a pattern very reminiscent of that seen at CFSs challenged
with APH (5). However, while most of the UFBs associated with
CFSs following APH treatment comprise dsDNA and hence are
coated with PICH, the folate stress-induced UFBs associated with
FRAXA are largely RPA-associated ssDNA, suggesting that the
source of the UFBs arising from these two types of fragile loci is
fundamentally different. Consistent with this, the folate stress-
induced RPA+ve UFBs are generally not associated with FANCD2,
an established marker of CFSs (5, 7). Moreover, we could show
that accumulation of RPA+ve UFBs depends on RAD51, which is
essential for HR. These data suggest that FRAXA-associated UFBs
represent predominantly unresolved HR intermediates, a new class
of UFB discovered recently (40, 41). Indeed, our data provide
evidence of an HR-dependent UFB derived from a specific locus
in human cells. We propose that, during folate stress, replication of
long CGG repeats is strongly perturbed, leading to replication fork
collapse that drives HR at this locus in the late G2 phase.
Based on the striking level of FRAXA missegregation in FM
cells, there seems little doubt that the cell struggles to replicate and
segregate such long CGG repeat loci. In line with this notion, it is
plausible that dietary folate deficiency could drive the FRAXA
mosaicism observed in FXS patients (42, 43). Similarly, our data
offer a potential explanation for the observation that ChrX an-
euploidy occurs in female carriers and male FXS patients. The fact
that we only observed FRAXA loss in tetraploid cells could simply
reflect the fact that loss of ChrX (or even just the ChrX telomere
region) (44) would probably be lethal to diploid male cells.
It is well established that PM alleles expand to FM from one
generation to the next (42–44), but the mechanism underlying this
expansion remains unknown. We have assessed whether folate
stress could induce rapid expansion in only a few cell generations.
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Although our results did not indicate clear expansion of the PM
allele, we did uncover evidence that the PM allele could contract
in length following a short period of folate stress, which is con-
sistent with the previous finding that CGG repeats can undergo
either contraction or expansion (44). Further investigation is
warranted to assess whether extended exposure to folate stress
might lead to more dramatic changes in the PM alleles.
Taken together, the data presented here allow us to propose a
model wherein the replication fork collapses at FM FRAXA CGG
repeats under folate stress conditions, which initiates HR in late
G2 phase (SI Appendix, Fig. S8). These HR intermediates persist
into mitotic anaphase and form FRAXA-associated ssDNA UFBs
or lagging chromatin. If these bridges and laggards fail to be re-
solved, which seems to occur in a significant proportion of the
cases, FRAXA DNA can missegregate or form micronuclei in the
next G1 phase. In some cases, FRAXA-associated UFBs in telo-
phase might trigger the abortion of cytokinesis and lead to binu-
cleation, presumably by activation of the abscission checkpoint
(45, 46). This could give the cells another chance to replicate and
divide, but inevitably would promote ChrX aneuploidy, and po-
tentially more general chromosomal instability.
In this study, a specific locus has been tracked in cells deprived
of folate and shown to be partitioned aberrantly between the
newly born daughter cells. The methodologies developed here
should facilitate future studies on replication stress and genomic
instability. In addition, considering that numerous CG-rich re-
peat regions exist in the genome of all individuals, particularly
those associated with CpG islands in gene promoters, further
studies are warranted focusing on those regions. It is conceivable
that folate deficiency could affect other, apparently nonpathological,
CG-rich repeat regions in the human genome, which, over time,
would drive progressive chromosome instability that has pathological
consequences.
Materials and Methods
The full details of cell lines, cell culture, cell synchronization, and treatment
are described in SI Appendix, Materials and Methods. The procedures for
Immunofluorescence (IF), FISH, FISH combined with IF, flow cytometry,
Western blot analysis, and the FMR1 CGG allele assay are described in SI
Appendix, Materials and Methods. Image and statistical analysis are also
described in SI Appendix,Materials and Methods. In addition, the FMR1 CGG
allele PCR capillary electrophoresis output plots are included as Dataset S1.
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